Updated Jul 16, 2026
Craig Adam R is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Adam R. Craig is the Executive Chairman and a Director at X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapies for rare immune system diseases. He has been involved in multiple SEC filings related to his roles at the company.
| Role | Executive Chairman, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-08-12 | XFOR | X4 Pharmaceuticals, Inc | A — Grant or award | 289.9K | $0.00 |
Adam R. Craig is the Executive Chairman and a Director at X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapies for rare immune system diseases. He has been involved in multiple SEC filings related to his roles at the company.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Craig Adam R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.